BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

DNA-based Down syndrome test diagnostic data

A blinded, prospective study of 449 blood samples from pregnant women at a high-risk for fetal chromosomal aneuploidy showed that Sequenom's DNA-based prenatal Down syndrome test had 99.7% specificity and 100% sensitivity for detecting fetal trisomy 21. The prospective...

Read the full 171 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >